Telix Pharmaceuticals (TLX) director discloses 3.63M indirect shares

Rhea-AI Filing Summary

Telix Pharmaceuticals Ltd director Nelson Mark Alexander has filed an initial Form 3 reporting his existing shareholdings. The filing shows indirect beneficial ownership of 3,628,750 Ordinary Shares held through MAN Holdings Pty Ltd, acting as trustee for the Nelson Hybrid Trust, of which he is a director and shareholder. This filing records his current position rather than any new share purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Nelson Mark Alexander

Role Director

Type	Security	Shares	Price	Value
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Ordinary Shares — 3,628,750 shares (Indirect, MAN Holdings Pty Ltd)

Footnotes (1)

1. [object Object]

Key Figures

Indirectly held Ordinary Shares: 3,628,750 shares

1 metrics

Indirectly held Ordinary Shares 3,628,750 shares Total shares following reported holding, via MAN Holdings Pty Ltd as trustee for the Nelson Hybrid Trust

Key Terms

Form 3, Ordinary Shares, indirect ownership, trustee, +1 more

5 terms

Form 3 regulatory

"Telix Pharmaceuticals Ltd director Nelson Mark Alexander has filed an initial Form 3 reporting his existing shareholdings."

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Ordinary Shares financial

"The filing shows indirect beneficial ownership of 3,628,750 Ordinary Shares held through MAN Holdings Pty Ltd"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

indirect ownership financial

"The filing reports indirect ownership of Ordinary Shares."

trustee financial

"held through MAN Holdings Pty Ltd, acting as trustee for the Nelson Hybrid Trust"

A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.

beneficial ownership financial

"This Form 3 reports his beneficial ownership position rather than any new share purchase or sale."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Nelson Mark Alexander

(Last) (First) (Middle)

C/O TELIX PHARMACEUTICALS LTD

55 FLEMINGTON RD

(Street)

NORTH MELBOURNE 3051

(City) (State) (Zip)

AUSTRALIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Telix Pharmaceuticals Ltd [ TLX ]

3a. Foreign Trading Symbol
[TLX]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	3,628,750	I	MAN Holdings Pty Ltd(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MAN Holdings Pty Ltd, as Trustee for the Nelson Hybrid Trust, of which Mr. Nelson is a director and shareholder.

Remarks:

Ex. 24 - Power of Attorney

	/s/ Oliver Newman, on behalf of Mr. Mark Nelson	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Telix Pharmaceuticals (TLX) director Nelson Mark Alexander report on this Form 3?

He reports indirect beneficial ownership of 3,628,750 Ordinary Shares. The shares are held through MAN Holdings Pty Ltd as trustee for the Nelson Hybrid Trust, where he is a director and shareholder. This records existing holdings, not a new trade.

How many Telix Pharmaceuticals (TLX) shares does MAN Holdings Pty Ltd hold for Nelson Mark Alexander?

The Form 3 states 3,628,750 Ordinary Shares are held indirectly. These shares are owned via MAN Holdings Pty Ltd, acting as trustee for the Nelson Hybrid Trust associated with Nelson Mark Alexander, reflecting his reported beneficial interest.

Does this Telix Pharmaceuticals (TLX) Form 3 show any recent insider buying or selling?

No, the Form 3 records holdings only and lists no buy or sell transactions. It reports a total indirect position of 3,628,750 Ordinary Shares, held through MAN Holdings Pty Ltd as trustee for the Nelson Hybrid Trust.

What type of ownership is reported by Telix Pharmaceuticals (TLX) director Nelson Mark Alexander?

The filing reports indirect ownership of Ordinary Shares. The shares are held by MAN Holdings Pty Ltd as trustee for the Nelson Hybrid Trust, with Nelson Mark Alexander described as a director and shareholder of that trustee entity.

Why is a Form 3 filing important for Telix Pharmaceuticals (TLX) investors?

Form 3 establishes an insider’s starting ownership position when they become a reporting person. For Telix, it shows director Nelson Mark Alexander’s indirect interest in 3,628,750 Ordinary Shares through a trust structure linked to him.